Fidelity Investments’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $31.8M | Sell |
|
|||||
|
2022
Q2 | $98.5M | Sell |
|
|||||
|
2022
Q1 | $142M | Sell |
|
|||||
|
2021
Q4 | $125M | Buy |
|
|||||
|
2021
Q3 | $76.6M | Buy |
|
|||||
|
2021
Q2 | $50.6M | Sell |
|
|||||
|
2021
Q1 | $119M | Sell |
|
|||||
|
2020
Q4 | $191M | Sell |
|
|||||
|
2020
Q3 | $367M | Sell |
|
|||||
|
2020
Q2 | $577M | Buy |
|
|||||
|
2020
Q1 | $428M | Buy |
|
|||||
|
2019
Q4 | $416M | Sell |
|
|||||
|
2019
Q3 | $296M | Sell |
|
|||||
|
2019
Q2 | $417M | Sell |
|
|||||
|
2019
Q1 | $446M | Buy |
|
|||||
|
2018
Q4 | $342M | Buy |
|
|||||
|
2018
Q3 | $297M | Buy |
|
|||||
|
2018
Q2 | $292M | Sell |
|
|||||
|
2018
Q1 | $349M | Buy |
|
|||||
|
2017
Q4 | $220M | Buy |
|
|||||
|
2017
Q3 | $162M | Sell |
|
|||||
|
2017
Q2 | $147M | Sell |
|
|||||
|
2017
Q1 | $212M | Buy |
|
|||||
|
2016
Q4 | $80.9M | Buy |
|
|||||
|
2016
Q3 | $129M | Buy |
|
|||||
|
2016
Q2 | $91.8M | Buy |
|
|||||
|
2016
Q1 | $72.5M | Buy |
|
|||||
|
2015
Q4 | $148M | Buy |
|
|||||
|
2015
Q3 | $186M | Buy |
|